Andrew
300 posts




































Nirman Agri Genetics Limited approved the financial results for the year ending March 31, 2025. Standalone YoY FY25 vs FY24 🟩 Revenue Up 273% At ₹236.52 Cr Vs ₹63.34 Cr 🟩 Tot. Rev Up 274% At ₹236.70 Cr Vs ₹63.34 Cr 🟩 Expenses Up 302% At ₹210.63 Cr Vs ₹52.40 Cr 🟩 PBT Up 138% At ₹26.07 Cr Vs ₹10.94 Cr 🟩 PAT Up 143% At ₹25.29 Cr Vs ₹10.40 Cr 🟩 Net Profit Up 143% At ₹25.29 Cr Vs ₹10.40 Cr 🟩 EPS (Basic) Up 81% At ₹31.57 Vs ₹17.46 🟩 EPS (Diluted) Up 81% At ₹31.57 Vs ₹17.46 HoH H2FY25 vs H1FY25 🟩 Revenue Up 10% At ₹124.07 Cr Vs ₹112.45 Cr 🟩 Tot. Rev Up 10% At ₹124.07 Cr Vs ₹112.45 Cr 🟩 Expenses Up 9% At ₹110.06 Cr Vs ₹100.56 Cr 🟩 PBT Up 18% At ₹14.01 Cr Vs ₹11.88 Cr 🟩 PAT Up 19% At ₹13.65 Cr Vs ₹11.45 Cr 🟩 Net Profit Up 19% At ₹13.65 Cr Vs ₹11.45 Cr 🟩 EPS (Basic) Up 19% At ₹17.04 Vs ₹14.30 🟩 EPS (Diluted) Up 19% At ₹17.04 Vs ₹14.30 YoY H2FY25 vs H2FY24 🟩 Revenue Up 215% At ₹124.07 Cr Vs ₹39.35 Cr 🟩 Tot. Rev Up 215% At ₹124.07 Cr Vs ₹39.35 Cr 🟩 Expenses Up 236% At ₹110.06 Cr Vs ₹32.76 Cr 🟩 PBT Up 112% At ₹14.01 Cr Vs ₹6.59 Cr 🟩 PAT Up 111% At ₹13.65 Cr Vs ₹6.48 Cr 🟩 Net Profit Up 111% At ₹13.65 Cr Vs ₹6.48 Cr 🟩 EPS (Basic) Up 57% At ₹17.04 Vs ₹10.87 🟩 EPS (Diluted) Up 57% At ₹17.04 Vs ₹10.87 QoQ Q4FY25 vs Q3FY25 🟩 Revenue Up 3% At ₹63.00 Cr Vs ₹61.07 Cr 🟩 Tot. Rev Up 3% At ₹63.00 Cr Vs ₹61.07 Cr 🟩 Expenses Up 3% At ₹55.84 Cr Vs ₹54.22 Cr 🟩 PBT Up 4% At ₹7.16 Cr Vs ₹6.85 Cr 🟩 PAT Up 3% At ₹6.92 Cr Vs ₹6.73 Cr 🟩 Net Profit Up 3% At ₹6.92 Cr Vs ₹6.73 Cr 🟩 EPS (Basic) Up 3% At ₹8.64 Vs ₹8.40 🟩 EPS (Diluted) Up 3% At ₹8.64 Vs ₹8.40 YoY Q4FY25 vs Q4FY24 🟩 Revenue Up 208% At ₹63.00 Cr Vs ₹20.46 Cr 🟩 Tot. Rev Up 208% At ₹63.00 Cr Vs ₹20.46 Cr 🟩 Expenses Up 228% At ₹55.84 Cr Vs ₹17.02 Cr 🟩 PBT Up 108% At ₹7.16 Cr Vs ₹3.44 Cr 🟩 PAT Up 107% At ₹6.92 Cr Vs ₹3.34 Cr 🟩 Net Profit Up 107% At ₹6.92 Cr Vs ₹3.34 Cr 🟩 EPS (Basic) Up 54% At ₹8.64 Vs ₹5.60 🟩 EPS (Diluted) Up 54% At ₹8.64 Vs ₹5.60











